Circulating Haptoglobin Is an Independent Prognostic Factor in the Sera of Patients with Epithelial Ovarian Cancer
Open Access
- 1 January 2007
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 9 (1), 1-7
- https://doi.org/10.1593/neo.06619
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort studyEuropean Journal Of Cancer, 2006
- Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylationInternational Journal of Cancer, 2006
- Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancerProteomics, 2005
- Expression of haptoglobin in human keratinocytes and Langerhans cellsBritish Journal of Dermatology, 2005
- Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemiaBlood, 2005
- Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancerCancer Letters, 1992
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Associations between the Two Serum Proteins Haptoglobin and Transferrin and LeukaemiaHuman Heredity, 1988
- Distribution of Alpha-l-Antitrypsin and Haptoglobin Phenotypes in Bladder Cancer PatientsHuman Heredity, 1987
- Haptoglobin Groups and Lung CancerHuman Heredity, 1986